News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
ALX Oncology
NEWS
JOBS
IN THE PRESS
NEWS
Business
BioSpace Movers & Shakers, May 8
Pharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
May 7, 2020
·
5 min read
·
Alex Keown
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
·
1 min read
Press Releases
ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004
January 9, 2026
·
5 min read
Press Releases
ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting
December 8, 2025
·
5 min read
Press Releases
ALX Oncology to Present at Upcoming Investor Conferences
November 19, 2025
·
1 min read
Press Releases
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 10, 2025
·
14 min read
Press Releases
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
October 31, 2025
·
2 min read
Press Releases
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
October 24, 2025
·
5 min read
Press Releases
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 6, 2025
·
3 min read
Press Releases
ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer
September 15, 2025
·
4 min read
Press Releases
ALX Oncology to Participate in Upcoming Investor Conferences in September 2025
September 1, 2025
·
1 min read
